Decreased Expression of Urethral Caveolin-1, -2, and -3 in the Rat Model of Overactive Bladder: Potential Mediator of Functional Interaction of Urethra and Urinary Bladder

키워드

참고문헌 (25)

1. Boscher C, "Caveolin-1 : role in cell signaling", Adv Exp Med Biol, 729, pp.29~50 (2012)
2. Williams TM, "The caveolin proteins", Genome Biol, 5, pp.214~ (2004)
3. Cohen AW, "Role of caveolae and caveolins in health and disease", Physiol Rev, 84, pp.1341~1379 (2004)
4. Scherer PE, "Cell-type and tissue-specific expression of caveolin-2 caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo", J Biol Chem, 272, pp.29337~29346 (1997)
5. Song KS, "Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins", J Biol Chem, 271, pp.15160~15165 (1996)
6. Williams TM, "The Caveolin genes : from cell biology to medicine", Ann Med, 36, pp.584~595 (2004)
7. Schwencke C, "Caveolae and caveolin in transmembrane signaling : Implications for human disease", Cardiovasc Res, 70, pp.42~49 (2006)
8. 김선옥, "Expression of Caveolin-1 in Rat Urinary Bladder with Cyclophosphamide-Induced Cystitis", International Neurourology Journal, 16(4), pp.169~174 (2012), 대한배뇨장애요실금학회[DOI]
9. Wise BG, "Prevalence and significance of urethral instability in women with detrusor instability", Br J Urol, 72, pp.26~29 (1993)
10. Chaliha C, "Changes in urethral function with bladder filling in the presence of urodynamic stress incontinence and detrusor overactivity", Am J Obstet Gynecol, 192, pp.60~65 (2005)
11. Zeng J, "Vasopressin-induced mouse urethral contraction is modulated by caveolin-1", Eur J Pharmacol, 750, pp.59~65 (2015)
12. Sancho M, "Altered neuronal and endothelial nitric oxide synthase expression in the bladder and urethra of cyclophosphamide-treated rats", Nitric Oxide, 39, pp.8~19 (2014)
13. Juszczak K, "Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and chronic cyclophosphamide treatment", J Physiol Pharmacol, 61, pp.477~482 (2010)
14. Bae JH, "The effects of a-adrenoceptor antagonists on the urethral perfusion pressure of the female rat", BJU Int, 96, pp.1131~1135 (2005)
15. Cristofaro V, "Smooth muscle caveolae differentially regulate specific agonist induced bladder contractions", Neurourol Urodyn, 26, pp.71~80 (2007)
16. Lai HH, "Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder", Neurochem Internat, 45, pp.1185~1193 (2004)
17. Cristofaro V, "Altered caveolar mediated purinergic signaling in spontaneously hypertensive rats with detrusor overactivity", J Urol, 188, pp.1017~1026 (2012)
18. Wantuch C, "Pharmacological validation of a model of cystitis pain in the mouse", Neurosci Lett, 421, pp.250~252 (2007)
19. Bjorling DE, "Models of inflammation of the lower urinary tract", Neurourol Urodyn, 30, pp.673~682 (2011)
20. De Groat WC, "The urothelium in overactive bladder : passive bystander or active participant?", Urology, 64(6 Suppl 1), pp.7~11 (2004)
21. Yoshimura N, "Lower urinary tract symptoms(LUTS)and bladder afferent activity", Neurourol Urodyn, 26(6 Suppl), pp.908~913 (2007)
22. Birder LA, "Urothelial signaling", Auton Neurosci, 153, pp.33~40 (2010)
23. Brading AF, "The physiology of the mammalian urinary outflow tract", Exp Physiol, 84, pp.215~221 (1999)
24. Sowa G, "Caveolae, caveolins, cavins, and endothelial cell function:new insights", Front Physiol, 2, pp.120~ (2012)
25. Ignarro LJ, "Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide", Proc Natl Acad Sci USA, 84, pp.9265~9269 (1987)

관련 논문AI추천